LAVAL, QC, Sept. 5, 2019 /PRNewswire/ - Crescita
Therapeutics Inc. (TSX: CTX) and (OTC US: CRRTF) (Crescita or the
Company), a Canadian commercial dermatology company with
manufacturing capabilities and a portfolio of non-prescription
skincare products and prescription drug products for the treatment
and care of skin conditions, diseases and their symptoms, today
announced that its executive chairman, Dan Chicoine will be
presenting at this year's Fall Investor Summit on Monday, September 16th at 1:00 p.m. eastern time in New York City. Mr. Chicoine accompanied by
Ms. Linda Kisa, Crescita's director of investor relations,
will also be meeting with investors one-on-one during the
event.
The Fall Investor Summit will take place at the Essex House,
featuring 160 companies and over 1,000 institutional and retail
investors.
About Crescita Therapeutics Inc.
Crescita (TSX:
CTX and OTC US: CRRTF) is a publicly traded, Canadian commercial
dermatology company with manufacturing capabilities and a portfolio
of non-prescription skincare products and prescription drug
products for the treatment and care of skin conditions and diseases
and their symptoms. Crescita owns multiple proprietary drug
delivery platforms that support the development of patented
formulations that can facilitate the delivery of active drugs into
or through the skin. Please visit
www.crescitatherapeutics.com for additional information.
About The Investor Summit
The Investor Summit
(formerly MicroCap Conference) is an exclusive, independent
conference dedicated to connecting small cap and microcap companies
with qualified investors.
To register as a presenting company: please contact Cassandra Miller
(cassandra@microcapconf.com)
To request complimentary investor registration: please visit our
website at www.microcapconf.com
FOR MORE INFORMATION
Please visit: www.microcapconf.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/crescita-therapeutics-inc-to-present-at-the-fall-investor-summit-on-september-16th-17th-in-new-york-city-300912188.html
SOURCE Crescita Therapeutics Inc.